Interleukin-6 mutein: To begin an Israeli trial in December

ImClone Systems Inc. (IMCL) Product: Interleukin-6 mutein, a variant of native IL-6 Indication: Thrombocytopenia in cancer patients who have received high-dose chemotherapy Status: To begin an Israeli...